{"name":"Novadip Biosciences","slug":"novadip-biosciences","ticker":"","exchange":"","domain":"","description":"Novadip Biosciences is a biotechnology company focused on developing innovative regenerative medicine solutions, particularly in the field of bone and cartilage repair. The company's lead product, NVD003, is in Phase 3 clinical trials, while other candidates are in earlier stages of development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMUlkbUo2d0Q0SHNwTXIzbmxqd1FDU2JHSWdVclN6ZUVOUVVsRjhJY0lvekItMGc3dV92cXV6dXFOX3NlX0pJcy0yV08ycVNVc19qcXUxOElyZVRJSEVGODBXV1JLMXE0SGhqcHlnRTRtOGcwN2V4UWstQXR6bWd3ZFB5Ml9BTXFwYlpGT0pVdG1fMktrNUhKTk96ei1FMHgzaXpGeGk0Ym8?oc=5","date":"2023-01-06","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—2 more C-suite members leave Galapagos island - Fierce Biotech","headline":"Chutes & Ladders—2 more C-suite members leave Galapagos island","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQYXB6aDhQUGRVOS00UjBuNk5SaTJsay1xbmcxdWF0UlRieC1Ic044eUFkTHowWEJmR04xUF9ZS0k4T0xCSEdVT2QwbG5QdW91SFc4Zm1SSDBwNzYtVkZHT0t5bEtCVnNUOG5pZUNQdEpLeDZhN29ud2V2S3BfV1lNd2NET1ZJQW5OQll3?oc=5","date":"2023-01-03","type":"pipeline","source":"Pharma Voice","summary":"The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences - Pharma Voice","headline":"The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1QZVByRnpqSm9kZFJHeHpiNUlDbk1SMnpZWnZ6eUtHand5eU90dHZTZ2ZNWnVXUEVmd1o3cm1KQ3hZaVJfVEs0MU1ydjJ1dERRYWk3SXJkbElqM3lwbzlHR1FVa3hBXzhMelhkV21pbmtTMHdNQkVPWXp3ck4?oc=5","date":"2022-12-21","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker: Enlaza launches with $61M; Enveda brings in $68M - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker: Enlaza launches with $61M; Enveda brings in $68M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNZzFkakp6M0x2S182RTBjQ29mNERLcnNxWmxfbDBMVW5FSkhzMC1rd2Z4bERfbWR0VldlVmJ4NDhZN0pDaTZvYkp4ZkN6RVpuV1RjODd0Q284NVUwNjJrT1VUWGdnaFZoTjVaZ2dLMXJBZTFaTWFGbk00UzVXWEV1OUFDQ0R0R3J1bmc?oc=5","date":"2022-12-08","type":"pipeline","source":"BioSpace","summary":"Stem Cell Therapy Market Size To Hold USD 18.7 Bn By 2030 - BioSpace","headline":"Stem Cell Therapy Market Size To Hold USD 18.7 Bn By 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPZU5yYlVrdnNrZU5KS2xwT3lIaWp4OW9CbGF6eTBKLWRyY0NwT2h4YVg2R0MxTDQ2N0o5bmQ0d29tcDVJX00yWVlVaFJCWktzdGRHN0ZVSWVFWGZyTlFlQ2VTZ3Z5SXBWSklvdGtlY3M5Q3U1ekhzdkNCMHl0TXpGV1o5MGFOQWl2M3lpOGlycjJGQjdlX0tWWEVhLWxJUlhnd0JDSA?oc=5","date":"2018-12-12","type":"pipeline","source":"PR Newswire","summary":"NOVADIP BIOSCIENCES Appoints Jeff Abbey as CEO - PR Newswire","headline":"NOVADIP BIOSCIENCES Appoints Jeff Abbey as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNZWt4a25oNWh1WS1wSjVVYUZYQ1o3dUN6a1NONk5ycm9oaXJRbUU4QV82N3ktWHd5NU5ZNFBIVlU3Wnp6WTRST2MzeWI2RVdkdEwtQTJUdmoxV0ZZZDdzNngtSk9FVDBtVmtLcHN4MUd4dnkzNmZXekZJT1ZiRXAwWVRkMEdDZ2EtTC1QZlVnMk4?oc=5","date":"2014-08-06","type":"pipeline","source":"Pharmafile","summary":"Precious Cells Group appoints NHS stem cell expert - Pharmafile","headline":"Precious Cells Group appoints NHS stem cell expert","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}